FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity

Simon Timbrell, Hosam Aglan, Angela Cramer, Phil Foden, David Weaver, Jonathan Pachter, Aoife Kilgallon, Robert B. Clarke, Gillian Farnie, Nigel J. Bundred

Open source

DOI: 10.1038/s41523-021-00263-3
Published: 2021-05-28
Container: npj Breast Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41523-021-00263-3,
  title = {FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity},
  author = {Simon Timbrell and Hosam Aglan and Angela Cramer and Phil Foden and David Weaver and Jonathan Pachter and Aoife Kilgallon and Robert B. Clarke and Gillian Farnie and Nigel J. Bundred},
  year = {2021},
  journal = {npj Breast Cancer},
  doi = {10.1038/s41523-021-00263-3},
  url = {https://doi.org/10.1038/s41523-021-00263-3}
}

RIS

TY  - JOUR
TI  - FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity
AU  - Simon Timbrell
AU  - Hosam Aglan
AU  - Angela Cramer
AU  - Phil Foden
AU  - David Weaver
AU  - Jonathan Pachter
AU  - Aoife Kilgallon
AU  - Robert B. Clarke
AU  - Gillian Farnie
AU  - Nigel J. Bundred
PY  - 2021
JO  - npj Breast Cancer
DO  - 10.1038/s41523-021-00263-3
UR  - https://doi.org/10.1038/s41523-021-00263-3
ER  -

APA

Timbrell, S., Aglan, H., Cramer, A., Foden, P., Weaver, D., Pachter, J., Kilgallon, A., Clarke, R. B., Farnie, G., & Bundred, N. J. (2021). FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity. npj Breast Cancer. https://doi.org/10.1038/s41523-021-00263-3

Source records

crossref · retrieved 2026-09-26T06:26:46.962Z